IBM's October 2026 earnings date arrived on October 21, and the reaction did not match the headline numbers. Revenue came in at $17.1 billion against roughly $16.8 billion expected. Operating EPS printed $2.95 against about $2.86 on the Street. Both lines beat. The stock fell about 5%.

That combination is the entire lesson from IBM's print, and it is the piece most of the coverage skipped: IBM beat the quarter and reaffirmed the year without raising it. On a tape where buyers are paying for acceleration, a reaffirmed guidance range is not enough, no matter how clean the quarter behind it looked.

IBM Earnings Date October 2026: The Scorecard

IBM released third-quarter results on October 21, 2026 at roughly 4:08 p.m. ET, with the conference call at 5:00 p.m. ET. Revenue was $17.1 billion, up 5% year over year and up 6% at constant currency. GAAP net income was $2.19 billion versus $1.744 billion a year earlier, and diluted EPS from continuing operations was $2.31, up 26%. Operating EPS, IBM's own measure, rose 11% to $2.95.

Segment detail explains both the strength and the ceiling. Software generated $7.8 billion, up 8% and up 9% at constant currency, and that was the clear engine of the quarter. Infrastructure rose 4%, or 5% at constant currency. Consulting was flat on a reported basis and up 2% at constant currency. A flat consulting line is what keeps full-year guidance exactly where it is, because consulting is where large AI transformation deals are supposed to show up first.

The Margin Line Nobody Wants To Talk About

GAAP gross margin came in at 56.8%, down 50 basis points year over year. Non-GAAP gross margin was 58.5%, down 20 basis points. Operating pre-tax margin expanded 70 basis points on IBM's non-GAAP measure, and that is the positive headline, but it was achieved partly through operating expense discipline rather than gross margin expansion. When revenue is accelerating and gross margin is compressing, the mix is usually software-heavy revenue carrying a hardware attach, which is exactly what a large AI build cycle looks like before it turns profitable.

Free cash flow was $3.0 billion for the quarter, up $0.7 billion year over year, with roughly $8 billion generated through the first nine months, up 8%. Management raised its full-year free cash flow growth expectation to more than $1 billion year over year and kept full-year constant-currency revenue growth at 4% to 5%, with currency now expected to be neutral rather than a drag. The quarterly dividend is $1.69 per share.

Read that guidance language carefully. Free cash flow was raised. Revenue was not. That is a cost and margin story, not a demand acceleration story, and the market priced it correctly.

Why A Clean Beat Sold Off

Three things stacked up. First, guidance was maintained rather than raised, and with 4% to 5% full-year growth reaffirmed after a July stumble, the bar for a rerating simply did not move. Second, flat consulting is a direct read on enterprise AI budgets, and the market treats that number as a demand signal for the entire enterprise software complex, not just for IBM. Third, valuation left no cushion: trailing EPS of about $11.27 puts IBM near 20 times earnings, which is undemanding for a durable dividend payer and expensive for a mid-single-digit grower.

IBM has now beaten estimates in six of the past eight quarters, with the second quarter of 2026 the lone period where it merely met them. A company with that hit rate does not get credit for the beat alone. It gets credit for the beat plus a raise, and the fourth quarter is now where that expectation sits.

What The Print Sets Up

The roughly 5% post-print drawdown resets the pre-earnings setup for the fourth quarter rather than ending it. The question for Q4 is narrower and considerably more answerable than the one that just resolved: can software sustain 8% to 9% constant-currency growth while consulting turns positive, and does gross margin stop giving back basis points? Both are inside management's control, and both are measurable on the January print.

For positioning, the asymmetry here differs from the AI infrastructure names that reported the same week. IBM is a cash flow and dividend story trading on growth credibility, not a multiple-expansion story. A raise to the revenue range is what moves the stock. Another reaffirm at these levels will likely produce the same reaction this week produced.

Next Steps

If you hold IBM into the next print, the decision point is the guidance range, not the headline EPS. If you are building a pre-earnings position, the post-print drawdown is where valuation support tends to get established, and roughly 20 times trailing earnings on a stock yielding above 3% at a $1.69 quarterly dividend is a defensible entry against a reaffirmed 4% to 5% growth range. Set your thesis check on consulting, because that single line tells you whether the AI spending story is actually reaching IBM's income statement.